Financial Management Professionals’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Management Professionals’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-846	Closed	-$45K	–	448
2016 Q1	$45K	Hold	846	–	–	0.02%	75
2015 Q4	$55K	Hold	846	–	–	0.03%	71
2015 Q3	$48K	Hold	846	–	–	0.03%	85
2015 Q2	$49K	Buy	+846	New	+$52.2K	0.02%	86
2014 Q2	–	Sell	-846	Closed	-$45K	–	264
2014 Q1	$45K	Hold	846	–	–	0.03%	89
2013 Q4	$34K	Hold	846	–	–	0.02%	105
2013 Q3	$32K	Hold	846	–	–	0.02%	111
2013 Q2	$33K	Buy	+846	New	+$32.9K	0.02%	105

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Financial Management Professionals's TEVA Position: Q2 2016 in Review

Financial Management Professionals sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 846 shares — an estimated $45K sold.

Financial Management Professionals first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $55K in Q4 2015. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

Financial Management Professionals reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Financial Management Professionals sold 846 Teva Pharmaceuticals shares in Q2 2016, an estimated $45K.
Financial Management Professionals first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Financial Management Professionals's Teva Pharmaceuticals position peaked at $55K in Q4 2015.
812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Financial Management Professionals's 13F filing for Q2 2016, filed 4 Aug 2016.